226 related articles for article (PubMed ID: 8782858)
1. Central vasopressin blockade enhances its peripheral release in response to peripheral osmotic stimulation in conscious rats.
Liu HW; Wang YX; Crofton JT; Funyu T; Share L
Brain Res; 1996 May; 719(1-2):14-22. PubMed ID: 8782858
[TBL] [Abstract][Full Text] [Related]
2. V2-receptor blockade enhances pressor response to vasopressin: gender difference.
Wang YX; Crofton JT; Liu H; Sato K; Share L
Life Sci; 1996; 59(8):695-703. PubMed ID: 8761020
[TBL] [Abstract][Full Text] [Related]
3. Endothelium-dependent relaxation of human saphenous veins in response to vasopressin and desmopressin.
Aldasoro M; Medina P; Vila JM; Otero E; Martinez-León JB; Lluch S
J Vasc Surg; 1997 Apr; 25(4):696-703. PubMed ID: 9129626
[TBL] [Abstract][Full Text] [Related]
4. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
Croiset G; De Wied D
Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
[TBL] [Abstract][Full Text] [Related]
5. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs.
Naitoh M; Suzuki H; Murakami M; Matsumoto A; Ichihara A; Nakamoto H; Yamamura Y; Saruta T
Am J Physiol; 1993 Oct; 265(4 Pt 2):R934-42. PubMed ID: 8238468
[TBL] [Abstract][Full Text] [Related]
6. Role of vasopressin in neurocardiogenic responses to hemorrhage in conscious rats.
Imai Y; Kim CY; Hashimoto J; Minami N; Munakata M; Abe K
Hypertension; 1996 Jan; 27(1):136-43. PubMed ID: 8591876
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.
Nakamura S; Yamamura Y; Itoh S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Ogawa H; Shinohara T; Kan K; Tanada Y; Teramoto S; Sumida T; Nakayama S; Sekiguchi K; Kambe T; Tsujimoto G; Mori T; Tominaga M
Br J Pharmacol; 2000 Apr; 129(8):1700-6. PubMed ID: 10780976
[TBL] [Abstract][Full Text] [Related]
8. Central effects of vasopressin and 1-desamino-8-D-arginine vasopressin (DDAVP) on interleukin-1 fever in the rat.
Naylor AM; Gubitz GJ; Dinarello CA; Veale WL
Brain Res; 1987 Jan; 401(1):173-7. PubMed ID: 2949799
[TBL] [Abstract][Full Text] [Related]
9. Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists.
Perucca J; Bichet DG; Bardoux P; Bouby N; Bankir L
J Am Soc Nephrol; 2008 Sep; 19(9):1721-31. PubMed ID: 18596120
[TBL] [Abstract][Full Text] [Related]
10. Effects of V1- and V2-vasopressin (AVP) antagonists on the pressor, AVP and atrial natriuretic peptide responses to a hypertonic saline infusion in conscious anephric rats.
Ota K; Kimura T; Inoue M; Funyu T; Shoji M; Sato K; Ohta M; Yamamoto T; Abe K
Eur J Endocrinol; 1995 Jul; 133(1):127-32. PubMed ID: 7627334
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of V2 vasopressin agonist and antagonists on blood pressure regulation in normotensive (WKY) and spontaneously hypertensive (SHR) rats.
Budzikowski A; Lon S; Paczwa P; Szczepanska-Sadowska E
J Auton Nerv Syst; 1992 Jun; 39(2):87-95. PubMed ID: 1430797
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors.
Cheng SW; North WG
Brain Res; 1989 Feb; 479(1):35-9. PubMed ID: 2522339
[TBL] [Abstract][Full Text] [Related]
13. In vivo diuretic effect of a new non-peptide arginine vasopressin antagonist, OPC-31260, in conscious rats.
Tsuboi Y; Ishikawa S; Fujisawa G; Okada K; Saito T
J Endocrinol; 1994 Nov; 143(2):227-34. PubMed ID: 7829988
[TBL] [Abstract][Full Text] [Related]
14. Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin.
Martínez MC; Vila JM; Aldasoro M; Medina P; Flor B; Lluch S
Br J Pharmacol; 1994 Oct; 113(2):419-24. PubMed ID: 7834191
[TBL] [Abstract][Full Text] [Related]
15. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin.
Ervin MG; Ross MG; Leake RD; Fisher DA
Am J Physiol; 1992 Apr; 262(4 Pt 2):R636-43. PubMed ID: 1566929
[TBL] [Abstract][Full Text] [Related]
16. Pressor and bradycardic effects of centrally administered relaxin in conscious rats.
Yang RH; Bunting S; Wyss JM; Berecek KH; Zhang L; Jin H
Am J Hypertens; 1995 Apr; 8(4 Pt 1):375-81. PubMed ID: 7619350
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide, but not vasopressin V2 receptor-mediated vasodilation, modulates vasopressin-induced renal vasoconstriction in rats.
Loichot C; Cazaubon C; De Jong W; Helwig JJ; Nisato D; Imbs JL; Barthelmebs M
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):319-26. PubMed ID: 10731046
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
Federico P; Veale WL; Pittman QJ
Am J Physiol; 1992 May; 262(5 Pt 2):R901-8. PubMed ID: 1534208
[TBL] [Abstract][Full Text] [Related]
19. Role of vasopressin V2 receptors in modulation of the renal cortico-papillary NaCl gradient.
Kompanowska-Jezierska E; Dobrowolski L; Sadowski J
Pflugers Arch; 1994 Oct; 428(3-4):410-4. PubMed ID: 7816563
[TBL] [Abstract][Full Text] [Related]
20. The effect of AVP-V2 receptor stimulation on local GFR in the rat kidney.
Roald AB; Tenstad O; Aukland K
Acta Physiol Scand; 2000 Feb; 168(2):351-9. PubMed ID: 10712572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
